Sequent Scientific Limited — Board Meeting, 16-12-2025: Outcome of Board Meeting
16-12-2025 | 06:50 pm
16-12-2025 | 06:50 pm
Sequent Scientific's board finalized amalgamation with Viyash, allotting 18.19 Cr shares and 2.03 Cr warrants (raised 92.52 Cr upfront). Dr. Haribabu Bodepudi appointed MD & Group CEO. Ramakant Singani is new CFO from Jan 1, 2026. Authorized capital increased to 886.15 Cr.
No comments yet. Be the first to comment!
